| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |